|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Mirati Therapeutics (NASDAQ: MRTX) through any online brokerage.
The latest price target for Mirati Therapeutics (NASDAQ: MRTX) was reported by Citigroup on June 4, 2021. The analyst firm set a price target for 0.00 expecting MRTX to fall to within 12 months (a possible -100.00% downside). 27 analyst firms have reported ratings in the last year.
The stock price for Mirati Therapeutics (NASDAQ: MRTX) is $166.56 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Mirati Therapeutics.
There is no upcoming split for Mirati Therapeutics.
Mirati Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.